In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Tarsus Pharmaceuticals Inc (NASDAQ: TARS) was $48.32 for the day, up 0.17% from the previous closing price of $48.24. In other words, the price has increased by $0.17 from its previous closing price. On the day, 0.52 million shares were traded. TARS stock price reached its highest trading level at $49.09 during the session, while it also had its lowest trading level at $47.72.
Ratios:
Our analysis of TARS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.38 and its Current Ratio is at 5.42. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on November 20, 2023, initiated with a Neutral rating and assigned the stock a target price of $19.
On July 18, 2023, William Blair started tracking the stock assigning a Outperform rating and target price of $44.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 12 ’24 when LINK WILLIAM J PHD sold 35,000 shares for $26.08 per share. The transaction valued at 912,961 led to the insider holds 0 shares of the business.
FLYING L PARTNERS XI LLC bought 35,000 shares of TARS for $939,750 on Aug 12 ’24. On Jun 18 ’24, another insider, Farrow Jeffrey S, who serves as the insider of the company, sold 10,445 shares for $27.47 each. As a result, the insider received 286,924 and left with 18,136 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARS now has a Market Capitalization of 1847123840 and an Enterprise Value of 1598823040. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.82 while its Price-to-Book (P/B) ratio in mrq is 7.77. Its current Enterprise Value per Revenue stands at 12.335 whereas that against EBITDA is -11.465.
Stock Price History:
Over the past 52 weeks, TARS has reached a high of $52.99, while it has fallen to a 52-week low of $15.60. The 50-Day Moving Average of the stock is 21.92%, while the 200-Day Moving Average is calculated to be 44.99%.
Shares Statistics:
TARS traded an average of 746.59K shares per day over the past three months and 783610 shares per day over the past ten days. A total of 34.21M shares are outstanding, with a floating share count of 32.56M. Insiders hold about 14.83% of the company’s shares, while institutions hold 109.61% stake in the company. Shares short for TARS as of 1730332800 were 8157528 with a Short Ratio of 10.93, compared to 1727654400 on 9951316. Therefore, it implies a Short% of Shares Outstanding of 8157528 and a Short% of Float of 22.23.
